Trevi Therapeutics

The Street will gain access this week to an investment in the only opioid marketed in the U.S. and Europe without being classified as a controlled substance. The IPO Trevi Therapeutics, Inc. will issue nearly 4.7 million shares on the Nasdaq under ticker TRVI, according to the firm’s S-1...

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed. Beyond Meat, Inc. (BYND) will issue 8.75 million shares between $19 and $21 Thursday on the Nasdaq. The offering represents 15.2 percent of outstanding shares and is...